Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe and North America. The aim of this clinical trial was to
compare NN1250 (insulin degludec (IDeg)), a soluble insulin basal analogue (SIBA), with
insulin glargine (IGlar), as add-on to subject's ongoing treatment with metformin and/or
DPP-4 (dipeptyl peptidase 4) inhibitors, in patients with type 2 diabetes being treated with
oral anti-diabetic drugs (OADs).